fibroblasts < fibrosis < fidelity

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by fibrosis

Number of relevant bibliographic references: 11.

Ident.	Authors (with country if any)	Title
000522 (2018)	Manon Launay [France] ; Antoine Roux [France] ; Laurence Beaumont [France] ; Benoit Douvry [France] ; Lucien Lecuyer [France] ; Emmanuel Douez [France] ; Clément Picard [France] ; Dominique Grenet [France] ; Vincent Jullien [France] ; Véronique Boussaud [France] ; Romain Guillemain [France] ; Eliane M. Billaud [France]	Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis.
000594 (2018)	Jing Li [République populaire de Chine] ; Chuxiong Zeng [République populaire de Chine] ; Beishi Zheng [République populaire de Chine] ; Chun Liu [République populaire de Chine] ; Min Tang [République populaire de Chine] ; Yan Jiang [République populaire de Chine] ; Yizhong Chang [République populaire de Chine] ; Weiping Song [République populaire de Chine] ; Yingxin Wang [République populaire de Chine] ; Changqing Yang [République populaire de Chine]	HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis.
000849 (2017)	Adam C. Labonte [États-Unis] ; Sun-Sang J. Sung [États-Unis] ; Lucas T. Jennelle [États-Unis] ; Aditya P. Dandekar [États-Unis] ; Young S. Hahn [États-Unis]	Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis.
000B59 (2016)	Yogesh M. Kulkarni [États-Unis] ; Sucharita Dutta [États-Unis] ; Anand Krishnan V. Iyer [États-Unis] ; Rajkumar Venkatadri [États-Unis] ; Vivek Kaushik [États-Unis] ; Vani Ramesh [États-Unis] ; Clayton A. Wright [États-Unis] ; Oliver John Semmes [États-Unis] ; Juan S. Yakisich [États-Unis] ; Neelam Azad [États-Unis]	A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.
000C37 (2015)	Faouzi Saliba [France] ; Frederik Nevens	Progression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen.
000D19 (2015)	Nicholas W. Keiser [États-Unis] ; Susan E. Birket ; Idil A. Evans ; Scott R. Tyler ; Adrianne K. Crooke ; Xingshen Sun ; Weihong Zhou ; Joseph R. Nellis ; Elizabeth K. Stroebele ; Kengyeh K. Chu ; Guillermo J. Tearney ; Mark J. Stevens ; J Kirk Harris ; Steven M. Rowe ; John F. Engelhardt	Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.
000D94 (2014)	Robert D. Junkins ; Craig Mccormick ; Tong-Jun Lin	The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections.
000E63 (2014)	Takayoshi Shirasaki [Japon] ; Masao Honda ; Tetsuro Shimakami ; Kazuhisa Murai ; Takayuki Shiomoto ; Hikari Okada ; Riuta Takabatake ; Akihiro Tokumaru ; Yoshio Sakai ; Taro Yamashita ; Stanley M. Lemon ; Seishi Murakami ; Shuichi Kaneko	Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
001312 (2011)	Danielle Brandman [États-Unis] ; Andrea Pingitore ; Jennifer C. Lai ; John P. Roberts ; Linda Ferrell ; Nathan M. Bass ; Norah A. Terrault	Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
001339 (2011)	Maurizio Renna [Royaume-Uni] ; Catherine Schaffner ; Karen Brown ; Shaobin Shang ; Marcela Henao Tamayo ; Krisztina Hegyi ; Neil J. Grimsey ; David Cusens ; Sarah Coulter ; Jason Cooper ; Anne R. Bowden ; Sandra M. Newton ; Beate Kampmann ; Jennifer Helm ; Andrew Jones ; Charles S. Haworth ; Randall J. Basaraba ; Mary Ann Degroote ; Diane J. Ordway ; David C. Rubinsztein ; R Andres Floto	Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.
001341 (2011)	Basant A. Abdulrahman [États-Unis] ; Arwa Abu Khweek ; Anwari Akhter ; Kyle Caution ; Sheetal Kotrange ; Dalia H A. Abdelaziz ; Christie Newland ; Roberto Rosales-Reyes ; Benjamin Kopp ; Karen Mccoy ; Richard Montione ; Larry S. Schlesinger ; Mikhail A. Gavrilin ; Mark D. Wewers ; Miguel A. Valvano ; Amal O. Amer	Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "fibrosis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "fibrosis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    fibrosis
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020